MapLight Therapeutics, Inc. (MPLT) Balance Sheet
As of 2026-06-30 (10-Q), MapLight Therapeutics, Inc. (MPLT) reported total assets of $368.3M, total liabilities of $20.0M and shareholders' equity of $348.3M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $71.6M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
MPLTMapLight Therapeutics, Inc.Follow MPLT — free
—
Price chart with a free account
- Market cap
- 369.6M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 1 Dec, in 38 days
| Line | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|
| Cash and equivalents | 46.7 | 71.6 | |
| Short-term investments | 258.4 | 233.1 | |
| Current assets | 324.7 | 318.8 | |
| Total assets | 479.5 | 368.3 | |
| Current liabilities | 16.2 | 19.3 | |
| Total liabilities | 21.1 | 20.0 | |
| Shareholders' equity | 458.4 | 348.3 |
USD millions · SEC XBRL
MapLight Therapeutics, Inc. — questions
- How much cash does MapLight Therapeutics, Inc. have?
- $71.6M in cash and cash equivalents as of 2026-06-30.
- What are MapLight Therapeutics, Inc.'s total assets?
- $368.3M as of 2026-06-30.
- What is MapLight Therapeutics, Inc.'s shareholders' equity?
- $348.3M as of 2026-06-30.
Every figure on this page comes from MapLight Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.